Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.67 USD | +7.27% | +0.92% | -37.34% |
05-09 | Pulse Biosciences, Inc. Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System | CI |
05-07 | Transcript : Pulse Biosciences, Inc., Q1 2024 Earnings Call, May 07, 2024 |
- Stock Market
- Equities
- PLSE Stock
- News Pulse Biosciences, Inc.
- MarketScreener Editorial Features